Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-Analysis

Publisher： Karger

E-ISSN： 1661-3805|12|1|48-52

ISSN： 1661-3791

Source： Breast Care, Vol.12, Iss.1, 2017-02, pp. : 48-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapy in Premenopausal Breast Cancer Patients

By  

Breast Care, Vol. 10, Iss. 5, 2015-0 ,pp. : 307-310

Karger

Access to resources Recommend Favorite

Triple Negative Breast Cancer versus Non-Triple Negative Breast Cancer Treated with Breast Conservation Surgery Followed by Radiotherapy: A Systematic Review and Meta-Analysis

By  

Breast Care, Vol. 10, Iss. 6, 2015-0 ,pp. : 413-416

Karger

Access to resources Recommend Favorite

Systemic Treatment in Premenopausal Patients with Breast Cancer

By  

Breast Care, Vol. 10, Iss. 5, 2015-0 ,pp. : 305-306

Karger

Access to resources Recommend Favorite

Surgery after Primary Systemic Chemotherapy in Patients with Breast Cancer

By  

Breast Care, Vol. 1, Iss. 6, 2006-12 ,pp. : 358-361

Karger

Access to resources Recommend Favorite

Neoadjuvant Dose-Dense and Dose-Intensified Chemotherapy in Breast Cancer - Review of the Literature

By  

Breast Care, Vol. 11, Iss. 1, 2016-02 ,pp. : 13-20

Karger

Access to resources Recommend Favorite